English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2358]
News [4933]
Articles [204]
Editorials [8]
Conferences [138]
elearning [14]
Serial radiation therapy is safe and effective as alternative treatment to systemic therapy for kidney cancer
Serial radiation therapy is safe and effective as alternative treatment to systemic therapy for kidney cancer
Fibroblasts could serve as new key to enhancing personalised treatment for lung cancer patients
Fibroblasts could serve as new key to enhancing personalised treatment for lung cancer patients
New life for a cancer drug that reprograms pain pathways to treat chronic pain
New life for a cancer drug that reprograms pain pathways to treat chronic pain
External-beam radiation therapy underused for people with liver cancer awaiting transplant
External-beam radiation therapy underused for people with liver cancer awaiting transplant
A new approach to treating leukaemia
A new approach to treating leukaemia
Metabolic memory plays a key role in breast cancer relapse
Metabolic memory plays a key role in breast cancer relapse
Genetic biomarker test predicts recurrence and survival outcomes for men with high-risk prostate cancer
Genetic biomarker test predicts recurrence and survival outcomes for men with high-risk prostate cancer
High-dose radiation thwarts tumour growth in patients with advanced lung cancer
High-dose radiation thwarts tumour growth in patients with advanced lung cancer
Surgery has survival benefits for male stage IV breast cancer patients who are receptive to systemic therapy
Surgery has survival benefits for male stage IV breast cancer patients who are receptive to systemic therapy
Nivolumab + chemotherapy receives European commission approval for patients with HER2 negative, advanced or metastatic gastric, gastroesophageal junction or oesophageal adenocarcinoma
Nivolumab + chemotherapy receives European commission approval for patients with HER2 negative, advanced or...
<1...155156157158159...494>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top